GRGUX
Price
$46.80
Change
+$0.48 (+1.04%)
Updated
Dec 20 closing price
RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

GRGUX vs RMFCX

Header iconGRGUX vs RMFCX Comparison
Open Charts GRGUX vs RMFCXBanner chart's image
Goldman Sachs Equity Income R6
Price$46.80
Change+$0.48 (+1.04%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
GRGUX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRGUX vs. RMFCX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRGUX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. GRGUX (404M). GRGUX (1.76) and RMFCX (1.69) have matching dividends . GRGUX was incepted earlier than RMFCX: GRGUX (9 years) vs RMFCX (23 years). GRGUX is a more actively managed with annual turnover of: 32.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than GRGUX: RMFCX (250) vs GRGUX (5000000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. GRGUX (8.39). RMFCX return over 5 years is better than : 37.80 vs. GRGUX (22.66).
GRGUXRMFCXGRGUX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD7.3809.92174%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets404M102B0%
Annual Yield % from dividends1.761.69104%
Returns for 1 year8.3911.1175%
Returns for 3 years8.0812.3865%
Returns for 5 years22.6637.8060%
Returns for 10 yearsN/A59.36-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA